Silvana Romina Goldszmid is an Argentine-American biologist researching tumor immunology.

in biochemistry and a Ph.D. in tumor immunology working on dendritic cell-based vaccines for melanoma immunotherapy from the University of Buenos Aires, part of which was performed as a visiting scholar in the laboratory of Ralph M. Steinman at the Rockefeller University.

[1][2] In 2009, Goldszmid returned to tumor immunology, joining laboratory of Giorgio Trinchieri [Wikidata] at CCR, NCI, as a staff scientist.

[3] Goldszmid has a long-standing interest in understanding the mechanisms governing the development, functional maturation and dynamics of the mononuclear phagocyte cellular network [e.g. dendritic cells, monocytes and macrophages] that plays an instrumental role in host defense.

[1] Goldszmid and her colleagues showed for the first time that the gut microbiota control the response to cancer immunotherapy and chemotherapy by modulating myeloid-cell functions in the tumor microenvironment.